Wright Lassiter III - 02 Jan 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Director
Signature
Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III
Issuer symbol
DGX
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
06 Jan 2025, 16:48:04 UTC
Previous filing
30 Dec 2024
Next filing
31 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Phantom Stock Units Award $0 +190 $0.000000 190 02 Jan 2025 Common Stock 190 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.